\u5eb7\u519b\u4ec1 \u4e8e\u5eb7 \u4e2d\u56fd\u8425\u517b\u5b66\u4f1a\u80bf\u7624\u8425\u517b\u7ba1\u7406\u5206\u4f1a<\/p>\n
\u4e2d\u56fd\u533b\u5b66\u79d1\u5b66\u9662 \u5317\u4eac\u534f\u548c\u533b\u5b66\u9662 \u5317\u4eac\u534f\u548c\u533b\u9662\u4e34\u5e8a\u8425\u517b\u79d1\uff0c\u5317\u4eac 100730<\/p>\n
\u901a\u4fe1\u4f5c\u8005\uff1a\u4e8e\u5eb7\uff0cEmail\uff1ayuk1997@sina.com<\/p>\n
\u63d0\u8981<\/p>\n
\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u53ea\u8981\u80c3\u80a0\u9053\u6709\u529f\u80fd\uff0c\u5e94\u9996\u9009\u53e3\u670d\u8425\u517b\u8865\u5145\uff08oral nutritional supplements\uff0cONS\uff09\u3002ONS\u53ef\u589e\u52a0\u8425\u517b\u6444\u5165\uff0c\u7ef4\u6301\u548c\u6539\u5584\u8425\u517b\u72b6\u6001\uff0c\u9632\u6b62\u4f53\u91cd\u51cf\u8f7b\uff0c\u589e\u52a0\u6297\u80bf\u7624\u6cbb\u7597\u8010\u53d7\u6027\uff0c\u6539\u5584\u60a3\u8005\u4e34\u5e8a\u7ed3\u5c40\uff0c\u63d0\u9ad8\u751f\u6d3b\u8d28\u91cf\u3002\u80bf\u7624\u60a3\u8005\u5bf9\u4e8eONS\u5236\u5242\u7684\u9009\u62e9\uff0c\u53ef\u80fd\u53d7\u5230\u80bf\u7624\u7c7b\u578b\u548c\u4f4d\u7f6e\u53ca\u6297\u80bf\u7624\u6cbb\u7597\u7b49\u56e0\u7d20\u7684\u5f71\u54cd\u3002\u4e3a\u66f4\u6709\u6548\u5730\u5bf9\u80bf\u7624\u60a3\u8005\u5b9e\u65bd\u89c4\u8303\u5316\u7ecf\u53e3\u8425\u517b\u652f\u6301\u6cbb\u7597\uff0c\u4e2d\u56fd\u8425\u517b\u5b66\u4f1a\u80bf\u7624\u8425\u517b\u7ba1\u7406\u5206\u4f1a\u7ec4\u7ec7\u4e34\u5e8a\u8425\u517b\u4e13\u5bb6\u548c\u80bf\u7624\u533b\u5b66\u4e13\u5bb6\uff0c\u7ed3\u5408\u6700\u65b0\u4e34\u5e8a\u8425\u517b\u6307\u5357\u548c\u7814\u7a76\u8bc1\u636e\uff0c\u5236\u5b9a\u672c\u5171\u8bc6\uff0c\u4ee5\u671f\u6307\u5bfc\u4e34\u5e8a\u8bca\u7597\uff0c\u4f7f\u80bf\u7624\u60a3\u8005\u83b7\u76ca\u3002\u3010\u5173\u952e\u8bcd\u3011 \u80bf\u7624\uff1b \u8425\u517b\u98ce\u9669\uff1b \u53e3\u670d\u8425\u517b\u8865\u5145\uff1b \u7279\u6b8a\u533b\u5b66\u7528\u9014\u914d\u65b9\u98df\u54c1\uff1b \u80a0\u5185\u8425\u517b<\/p>\n
\u80bf\u7624\u60a3\u8005\u8425\u517b\u98ce\u9669\u548c\u8425\u517b\u4e0d\u826f\u53d1\u751f\u7387\u9ad8\uff3b1-2\uff3d\u3002\u5728\u80bf\u7624\u7684\u6cbb\u7597\u4e0e\u5eb7\u590d\u4e2d\uff0c\u5408\u7406\u7684\u8425\u517b\u652f\u6301\u6cbb\u7597\u53ef\u7ea0\u6b63\u80bf\u7624\u60a3\u8005\u8425\u517b\u4e0d\u826f\uff0c\u589e\u52a0\u6297\u80bf\u7624\u6cbb\u7597\u7684\u8010\u53d7\u6027\uff0c\u63a7\u5236\u6297\u80bf\u7624\u6cbb\u7597\u7684\u4e0d\u826f\u53cd\u5e94\u548c\u6539\u5584\u60a3\u8005\u751f\u6d3b\u8d28\u91cf\uff3b3-4\uff3d\u3002\u4f46\u9700\u8981\u6307\u51fa\uff0c\u4e0e\u5355\u7eaf\u7684\u8425\u517b\u4e0d\u826f\u6cbb\u7597\u4e0d\u540c\uff0c\u8425\u517b\u652f\u6301\u6cbb\u7597\u53ea\u662f\u80bf\u7624\u7efc\u5408\u6cbb\u7597\u7684\u4e00\u90e8\u5206\uff0c\u82e5\u5176\u4ed6\u6cbb\u7597\u63aa\u65bd\u4e0d\u53ca\u65f6\uff0c\u5355\u4e00\u8425\u517b\u652f\u6301\u6cbb\u7597\u53ef\u80fd\u65e0\u6548\uff3b5\uff3d\u3002\u8003\u8651\u5230\u80bf\u7624\u548c\u6297\u80bf\u7624\u6cbb\u7597\u4f1a\u5f71\u54cd\u5230\u60a3\u8005\u7684\u8425\u517b\u72b6\u6001\uff0c\u6240\u4ee5\u80bf\u7624\u60a3\u8005\u4e00\u7ecf\u8bca\u65ad\u540e\u5c31\u5e94\u8fdb\u884c\u8425\u517b\u98ce\u9669\u7b5b\u67e5\u3002\u5bf9\u5b58\u5728\u8425\u517b\u98ce\u9669\u8005\uff0c\u5e94\u5c3d\u65e9\u5f00\u59cb\u8425\u517b\u7ba1\u7406\uff3b6\uff3d\u3002\u5bf9\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u53ea\u8981\u80c3\u80a0\u9053\u529f\u80fd\u5141\u8bb8\uff0c\u5e94\u9996\u9009\u53e3\u670d\u8425\u517b\u8865\u5145\uff08oral nutritional supplements\uff0cONS\uff09\uff0c\u5305\u62ec\u7279\u6b8a\u533b\u5b66\u7528\u9014\u914d\u65b9\u98df\u54c1\uff08food for special medical purpose\uff0cFSMP\uff09\u548c\uff08\u6216\uff09\u53e3\u670d\u7684\u80a0\u5185\u8425\u517b\u5236\u5242\u3002ONS\u4e0d\u80fd\u6444\u5165\u6216\u4e0d\u8db3\u8005\uff0c\u5e94\u8003\u8651\u7ba1\u9972\u80a0\u5185\u8425\u517b\u6216\u80a0\u5916\u8425\u517b\uff3b3\uff3d\u3002\u80bf\u7624\u60a3\u8005\u63a5\u53d7ONS\u53ef\u589e\u52a0\u80fd\u91cf\u3001\u86cb\u767d\u548c\u5fae\u91cf\u8425\u517b\u7d20\u6444\u5165\uff0c\u7ef4\u6301\u548c\u6539\u5584\u8425\u517b\u72b6\u6001\uff0c\u9632\u6b62\u4f53\u91cd\u51cf\u8f7b\u548c\u6539\u5584\u751f\u6d3b\u8d28\u91cf\uff3b7-9\uff3d\u3002\u4e0d\u540c\u4e8e\u975e\u80bf\u7624\u6210\u4eba\u60a3\u8005\uff0c\u80bf\u7624\u60a3\u8005\u5bf9\u4e8eONS\u548cFSMP\u7684\u9009\u62e9\uff0c\u53ef\u80fd\u53d7\u5230\u80bf\u7624\u7c7b\u578b\u3001\u4f4d\u7f6e\u53ca\u6297\u80bf\u7624\u6cbb\u7597\u7b49\u56e0\u7d20\u7684\u5f71\u54cd\u3002\u4e3a\u66f4\u6709\u6548\u5730\u5bf9\u80bf\u7624\u60a3\u8005\u5b9e\u65bd\u89c4\u8303\u5316\u7ecf\u53e3\u8425\u517b\u652f\u6301\u6cbb\u7597\uff0c\u4e2d\u56fd\u8425\u517b\u5b66\u4f1a\u80bf\u7624\u8425\u517b\u7ba1\u7406\u5206\u4f1a\u7ec4\u7ec7\u4e34\u5e8a\u8425\u517b\u4e13\u5bb6\u548c\u80bf\u7624\u533b\u5b66\u4e13\u5bb6\uff0c\u7ed3\u5408\u6700\u65b0\u4e34\u5e8a\u8425\u517b\u6307\u5357\u3001\u7814\u7a76\u8bc1\u636e\u53ca\u4e34\u5e8a\u5b9e\u8df5\u7ecf\u9a8c\uff0c\u5236\u8ba2\u672c\u5171\u8bc6\uff0c\u4f9b\u4e34\u5e8a\u533b\u751f\u548c\u4e34\u5e8a\u8425\u517b\u533b\u5e08\u7b49\u4e13\u4e1a\u4eba\u5458\u53c2\u8003\u3002<\/p>\n
1 \u5171\u8bc6\u5236\u5b9a\u65b9\u6cd5<\/p>\n
\u4e2d\u56fd\u8425\u517b\u5b66\u4f1a\u80bf\u7624\u8425\u517b\u7ba1\u7406\u5206\u4f1a\u7ec4\u7ec7\u591a\u5b66\u79d1\u4e13\u5bb6\u8ba8\u8bba\u4e86\u5171\u8bc6\u7684\u603b\u4f53\u6846\u67b6\uff0c\u7ec4\u5efa\u4e86\u5171\u8bc6\u5236\u8ba2\u5de5\u4f5c\u7ec4\uff0c\u7ed3\u5408\u6700\u65b0\u4e34\u5e8a\u8425\u517b\u6307\u5357\u3001\u7814\u7a76\u8bc1\u636e\u53ca\u4e34\u5e8a\u5b9e\u8df5\u7ecf\u9a8c\uff0c\u786e\u5b9a\u4e86\u5171\u8bc6\u62df\u89e3\u51b3\u7684\u95ee\u9898\uff0c\u8bbe\u5b9a\u8bc1\u636e\u68c0\u7d22\u7b56\u7565\uff08\u88681\uff09\uff0c\u5254\u9664\u91cd\u590d\u3001\u57fa\u7840\u7814\u7a76\u3001\u8bc4\u8bba\u3001\u4f1a\u8bae\u6458\u8981\u7b49\u6587\u732e\u540e\uff0c\u5171\u5f97\u523089\u7bc7\u4e34\u5e8a\u76f8\u5173\u6587\u732e\u4f5c\u4e3a\u53c2\u8003\uff0c\u5236\u5b9a\u672c\u5171\u8bc6\u3002\u672c\u5171\u8bc6\u4e2d\u91c7\u7528\u5206\u7ea7\u7684\u8bc4\u4f30\uff0c\u5236\u8ba2\u4e0e\u8bc4\u4ef7\u5de5\u4f5c\u7ec4\u63d0\u4f9b\u7684\u8bc1\u636e\u7ea7\u522b\uff08\u9ad8\u3001\u4e2d\u3001\u4f4e\u3001\u6781\u4f4e\uff09\u548c\u63a8\u8350\u5f3a\u5ea6\u5206\u7ea7\uff08\u5f3a\u3001\u5f31\uff09\u7cfb\u7edf\uff08\u88682\uff09\uff0c\u5e94\u7528\u5fb7\u5c14\u83f2\u6d41\u7a0b\u8fdb\u884c\u8c03\u7814\u548c\u7ebf\u4e0a\u6295\u7968\uff0c\u8bbe\u7f6e\u540c\u610f\u3001\u57fa\u672c\u540c\u610f\u3001\u4e0d\u660e\u786e\u610f\u89c1\u548c\u4e0d\u540c\u610f\uff0c\u7ecf\u4e13\u5bb6\u7ec4\u65e0\u8bb0\u540d\u6295\u7968\uff0c\u6bcf\u6761\u63a8\u8350\u610f\u89c1\u7684\u540c\u610f\u548c\u57fa\u672c\u540c\u610f\u6bd4\u4f8b\u226575%\u5f62\u6210\u4e13\u5bb6\u5171\u8bc6\uff3b10-12\uff3d\u3002\u540c\u65f6\uff0c\u5171\u8bc6\u5236\u8ba2\u5de5\u4f5c\u7ec4\u4f1a\u5b9a\u671f\u76d1\u6d4b\u672c\u9886\u57df\u7684\u65b0\u7814\u7a76\u548c\u65b0\u8bc1\u636e\uff0c\u4ee5\u786e\u4fdd\u5171\u8bc6\u7684\u53ca\u65f6\u66f4\u65b0\uff0c\u66f4\u65b0\u8fc7\u7a0b\u5e94\u9075\u5faa\u4e0e\u521d\u6b21\u5236\u5b9a\u7c7b\u4f3c\u7684\u6d41\u7a0b\u3002<\/p>\n
2 \u80bf\u7624\u60a3\u8005\u7684\u8425\u517b\u98ce\u9669\u7b5b\u67e5\u548c\u8bc4\u5b9a<\/p>\n
\u63a8\u8350\u610f\u89c11\uff1a\u80bf\u7624\u60a3\u8005\u4e00\u7ecf\u786e\u8bca\uff0c\u5373\u5e94\u8fdb\u884c\u8425\u517b\u98ce\u9669\u7b5b\u67e5\u3001\u8425\u517b\u8bc4\u5b9a\u548c\u8425\u517b\u4e0d\u826f\u8bca\u65ad\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u9ad8\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
\u5bf9\u80bf\u7624\u60a3\u8005\u8fdb\u884c\u8425\u517b\u98ce\u9669\u7b5b\u67e5\uff0c\u4ee5\u5224\u65ad\u60a3\u8005\u662f\u5426\u5b58\u5728\u8425\u517b\u652f\u6301\u6cbb\u7597\u7684\u9002\u5e94\u8bc1\u3002\u5efa\u8bae\u6210\u5e74\u60a3\u8005\u91c7\u7528\u8425\u517b\u98ce\u9669\u7b5b\u67e52002\u8fdb\u884c\u8425\u517b\u98ce\u9669\u7b5b\u67e5\u3002\u8425\u517b\u98ce\u9669\u7b5b\u67e52002\u8bc4\u5206\u22653\u5206\u8005\uff0c\u8868\u660e\u5b58\u5728\u8425\u517b\u98ce\u9669\uff3b3\uff0c6\uff0c13-16\uff3d\u3002\u5bf9\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u60a3\u8005\uff0c\u5e94\u8fdb\u884c\u8425\u517b\u72b6\u51b5\u8bc4\u5b9a\uff0c\u53ef\u91c7\u7528\u60a3\u8005\u4e3b\u89c2\u6574\u4f53\u8bc4\u4f30\u91cf\u8868\u4f5c\u4e3a\u80bf\u7624\u60a3\u8005\u7684\u8425\u517b\u8bc4\u5b9a\u5de5\u5177\uff3b17-19\uff3d\u3002\u80bf\u7624\u60a3\u8005\u7684\u8425\u517b\u8bc4\u5b9a\uff0c\u5e94\u5305\u62ec\u81b3\u98df\u6444\u5165\u3001\u8eab\u4f53\u6210\u5206\u3001\u4f53\u529b\u6d3b\u52a8\u53ca\u4e3b\u8981\u4ee3\u8c22\u6307\u6807\u7b49\u53cd\u6620\u60a3\u8005\u673a\u4f53\u50a8\u5907\u53ca\u529f\u80fd\u72b6\u6001\u7684\u5185\u5bb9\uff0c\u8fd8\u5e94\u8003\u8651\u5230\u80bf\u7624\u672c\u8eab\u548c\u6297\u80bf\u7624\u6cbb\u7597\u5bf9\u60a3\u8005\u7684\u5f71\u54cd\u3002<\/p>\n
\u91c7\u7528\u5168\u7403\u8425\u517b\u9886\u5bfc\u5c42\u8bca\u65ad\u8425\u517b\u4e0d\u826f\u6807\u51c6\u8fdb\u884c\u8425\u517b\u4e0d\u826f\u8bca\u65ad\uff0c\u5176\u6d41\u7a0b\u5305\u62ec\uff1a\u7b2c\u4e00\u6b65\u8fdb\u884c\u8425\u517b\u98ce\u9669\u7b5b\u67e5\uff1b\u7b2c\u4e8c\u6b65\u5728\u7b5b\u67e5\u9633\u6027\u7684\u57fa\u7840\u4e0a\uff0c\u9700\u81f3\u5c11\u7b26\u54083\u4e2a\u8868\u73b0\u578b\u6307\u6807\u4e4b\u4e00\u548c2\u4e2a\u75c5\u56e0\u5b66\u6307\u6807\u4e4b\u4e00\uff0c\u53ef\u8bca\u65ad\u8425\u517b\u4e0d\u826f\uff3b20-22\uff3d\u3002<\/p>\n
\u6839\u636e\u80bf\u7624\u60a3\u8005\u7684\u8425\u517b\u72b6\u51b5\u3001\u80c3\u80a0\u9053\u529f\u80fd\u548c\u75be\u75c5\u4e25\u91cd\u7a0b\u5ea6\uff0c\u5236\u5b9a\u5e76\u5b9e\u65bd\u4e2a\u4f53\u5316\u7684\u8425\u517b\u652f\u6301\u6cbb\u7597\u65b9\u6848\uff3b23\uff3d\u3002<\/p>\n
3 \u80bf\u7624\u60a3\u8005\u7684\u8425\u517b\u6444\u5165\u76ee\u6807<\/p>\n
\u63a8\u8350\u610f\u89c12\uff1a\u5efa\u8bae\u6210\u5e74\u80bf\u7624\u60a3\u8005\u80fd\u91cf\u6444\u5165105\uff5e126 kJ\/\uff08kg\u00b7d\uff09\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
\u63a8\u8350\u610f\u89c13\uff1a\u5bf9\u809d\u80be\u529f\u80fd\u6b63\u5e38\u7684\u6210\u5e74\u80bf\u7624\u60a3\u8005\uff0c\u5efa\u8bae\u86cb\u767d\u8d28\u6444\u51651\uff5e1.5 g\/\uff08kg\u00b7d\uff09\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4e2d\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
\u63a8\u8350\u610f\u89c14\uff1a\u5e94\u5e38\u89c4\u76d1\u6d4b\u80bf\u7624\u60a3\u8005\u7684\u7ef4\u751f\u7d20\u548c\u77ff\u7269\u8d28\u72b6\u51b5\uff0c\u5bf9\u7f3a\u4e4f\u8005\u5e94\u4e88\u5f3a\u5316\u8865\u5145\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
\u80bf\u7624\u60a3\u8005\u5e38\u5904\u4e8e\u9ad8\u4ee3\u8c22\u72b6\u6001\uff0c\u80fd\u91cf\u6d88\u8017\u91cf\u589e\u52a0\u3002\u80bf\u7624\u672c\u8eab\u548c\u6297\u80bf\u7624\u6cbb\u7597\u5747\u53ef\u5f15\u8d77\u9aa8\u9abc\u808c\u840e\u7f29\u3001\u7626\u4f53\u7ec4\u7ec7\u51cf\u5c11\u548c\u5185\u810f\u86cb\u767d\u6d88\u8017\uff3b23-24\uff3d\u3002\u5bf9\u80bf\u7624\u60a3\u8005\u8425\u517b\u6cbb\u7597\u7684\u4e3b\u8981\u76ee\u7684\u5728\u4e8e\u589e\u52a0\u8425\u517b\u7684\u6444\u5165\u3001\u7ef4\u6301\u5145\u8db3\u7684\u86cb\u767d\u8d28\u50a8\u5b58\u4ee5\u53ca\u4f53\u7ec6\u80de\u91cf\u3001\u9632\u6b62\u4f53\u91cd\u51cf\u8f7b\u3002\u8425\u517b\u6cbb\u7597\u7684\u524d\u63d0\u662f\u9700\u8981\u4fdd\u8bc1\u80bf\u7624\u60a3\u8005\u80fd\u91cf\u3001\u86cb\u767d\u8d28\u548c\u5fae\u91cf\u8425\u517b\u7d20\u7684\u6444\u5165\uff3b25\uff3d\u3002<\/p>\n
\u6b27\u6d32\u80a0\u5916\u80a0\u5185\u8425\u517b\u5b66\u4f1a\u6307\u5357\u63a8\u8350\u6210\u5e74\u80bf\u7624\u60a3\u8005\u80fd\u91cf\u6444\u5165105\uff5e126 kJ\/\uff08kg\u00b7d\uff09\uff3b3\uff3d\u3002\u5bf9\u4e8e\u673a\u68b0\u901a\u6c14\u60a3\u8005\uff0c\u53ef\u4f7f\u7528\u95f4\u63a5\u80fd\u91cf\u4ee3\u8c22\u6d4b\u5b9a\u51c6\u786e\u8bc4\u4f30\u80fd\u91cf\u9700\u6c42\uff3b26-27\uff3d\u3002\u5982\u5408\u5e76\u5371\u91cd\u75c7\u65e9\u671f\uff0c\u53ef\u91c7\u7528\u4f4e\u80fd\u91cf\u8425\u517b\u652f\u6301\uff08<70%\u76ee\u6807\u80fd\u91cf\uff09\uff0c3\uff5e7 d\u540e\u9010\u6b65\u8fbe\u5230\u76ee\u6807\u91cf\uff3b26\uff3d\u3002<\/p>\n
\u809d\u3001\u80be\u529f\u80fd\u6b63\u5e38\u7684\u6210\u5e74\u80bf\u7624\u60a3\u8005\uff0c\u5efa\u8bae\u86cb\u767d\u8d28\u6444\u51651\uff5e1.5 g\/\uff08kg\u00b7d\uff09\uff3b3\uff3d\u3002\u5bf9\u4e8e\u5408\u5e76\u5371\u91cd\u75c7\u8005\uff0c\u53ef\u6839\u636e\u4e34\u5e8a\u9700\u6c42\u7ed9\u4e881.5\uff5e2.0 g\/\uff08kg\u00b7d\uff09\uff3b26\uff3d\u3002<\/p>\n
\u5e94\u5e38\u89c4\u76d1\u6d4b\u80bf\u7624\u60a3\u8005\u7684\u7ef4\u751f\u7d20\u548c\u77ff\u7269\u8d28\uff08\u5e38\u91cf\u5143\u7d20\u53ca\u5fae\u91cf\u5143\u7d20\uff09\u72b6\u51b5\uff0c\u5bf9\u7f3a\u4e4f\u8005\u5e94\u4e88\u5f3a\u5316\u8865\u5145\uff3b28-29\uff3d\u3002\u5bf9\u957f\u671f\u8425\u517b\u4e0d\u826f\uff0c\u5df2\u5b58\u5728\u4f4e\u78f7\u3001\u4f4e\u94be\u8840\u75c7\u7684\u80bf\u7624\u60a3\u8005\uff0c\u9700\u7ea0\u6b63\u7535\u89e3\u8d28\u7d0a\u4e71\uff0c\u6ce8\u610f\u7ef4\u751f\u7d20B1\u8865\u5145\uff0c\u9884\u9632\u518d\u5582\u517b\u7efc\u5408\u5f81\uff3b30-32\uff3d\u3002<\/p>\n
4 \u80bf\u7624\u60a3\u8005\u7684\u53e3\u670d\u8425\u517b\u8865\u5145<\/p>\n
\u63a8\u8350\u610f\u89c15\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\/\u4e0d\u826f\u7684\u80bf\u7624\u60a3\u8005\uff0c\u53ea\u8981\u80c3\u80a0\u9053\u6709\u529f\u80fd\uff0c\u5e94\u9996\u9009ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4e2d\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
ONS\u53ef\u663e\u8457\u6539\u5584\u80bf\u7624\u60a3\u8005\u7684\u8425\u517b\u72b6\u6001\u3001\u751f\u6d3b\u8d28\u91cf\u548c\u4e34\u5e8a\u7ed3\u5c40\uff3b33\uff3d\u3002\u5bf9\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u81ea\u7136\u996e\u98df\u4e0d\u80fd\u6ee1\u8db3\u8425\u517b\u9700\u8981\u65f6\uff0c\u5728\u80c3\u80a0\u9053\u529f\u80fd\u5141\u8bb8\u7684\u6761\u4ef6\u4e0b\uff0c\u5e94\u9996\u9009ONS\uff08\u5305\u62ecFSMP\u53ca\u53e3\u670d\u80a0\u5185\u8425\u517b\u5236\u5242\uff09\uff3b3\uff0c34-35\uff3d\u3002\u5728\u5934\u9888\u90e8\u3001\u80f8\u90e8\u548c\u80c3\u80a0\u9053\u653e\u7597\u671f\u95f4\uff0c\u5982\u60a3\u8005\u5b58\u5728\u8425\u517b\u98ce\u9669\uff0c\u53ef\u4f7f\u7528ONS\u6765\u6ee1\u8db3\u8425\u517b\u6444\u5165\uff3b36-38\uff3d\u3002\u63a5\u53d7\u5316\u7597\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u8425\u517b\u98ce\u9669\uff0c\u53ef\u4f7f\u7528ONS\u4ee5\u589e\u52a0\u8010\u53d7\u6027\u548c\u63d0\u9ad8\u751f\u6d3b\u8d28\u91cf\uff3b39-40\uff3d\u3002\u63a5\u53d7\u8179\u90e8\u5927\u624b\u672f\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u8425\u517b\u98ce\u9669\uff0c\u5728\u672f\u524d5\uff5e7 d\u5373\u53ef\u7ed9\u4e88ONS\uff3b41-44\uff3d\u3002\u5bf9\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u8001\u5e74\u80bf\u7624\u60a3\u8005\uff0c\u5efa\u8bae\u6bcf\u5929\u6700\u5c11\u6444\u51651 674 kJ\u3001\u86cb\u767d\u8d2830 g\u4ee5\u4e0a\u7684ONS\uff3b45\uff3d\uff0c\u5e76\u6839\u636e\u8425\u517b\u72b6\u51b5\uff0c\u4e2a\u4f53\u5316\u8c03\u6574\u8865\u5145\u5242\u91cf\uff0c\u4ee5\u6ee1\u8db3\u60a3\u8005\u80fd\u91cf\u548c\u86cb\u767d\u8d28\u9700\u6c42\u3002\u540c\u65f6\u53ef\u7ed3\u5408\u5176\u53e3\u5473\u4e60\u60ef\u548c\u504f\u597d\u7b49\uff0c\u5c11\u91cf\u591a\u6b21\uff0c\u5c0f\u53e3\u555c\u996e\uff0c\u5728\u4f7f\u7528\u8fc7\u7a0b\u4e2d\u5e94\u6ce8\u610f\u76d1\u6d4bONS\u7684\u8010\u53d7\u6027\uff3b45\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c16\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5927\u591a\u6570ONS\u53ef\u9009\u62e9\u6807\u51c6\u7684\u6574\u86cb\u767d\u914d\u65b9\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4e2d\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5927\u591a\u6570\u9009\u62e9\u6807\u51c6\u914d\u65b9\u7684ONS\u5373\u53ef\uff3b3\uff3d\u3002\u6b27\u6d32\u80a0\u5916\u80a0\u5185\u8425\u517b\u5b66\u4f1a\u6307\u5357\u5efa\u8bae\uff0c\u5bf9\u4e8e\u65e0\u660e\u786e\u80a0\u529f\u80fd\u8870\u7aed\u7684\u5371\u91cd\u60a3\u8005\u3001\u80f0\u817a\u708e\u60a3\u8005\u6216\u708e\u6027\u80a0\u75c5\u60a3\u8005\uff0c\u5747\u53ef\u9009\u62e9\u6807\u51c6\u914d\u65b9\u7684ONS\uff3b26-27\uff0c46-47\uff3d\u3002\u5982\u80bf\u7624\u60a3\u8005\u5c45\u5bb6\u8fdb\u884c\u80a0\u5185\u8425\u517b\uff0c\u5728\u6ca1\u6709\u8179\u6cfb\u3001\u4fbf\u79d8\u6216\u7cd6\u5c3f\u75c5\u7684\u60c5\u51b5\u4e0b\uff0c\u5e94\u6839\u636e\u8425\u517b\u533b\u5e08\u7684\u6307\u5bfc\u4f7f\u7528\u6807\u51c6\u7684\u6574\u86cb\u767d\u914d\u65b9\uff3b48\uff3d\u3002\u5bf9\u63a5\u53d7\u8179\u90e8\u5927\u624b\u672f\u7684\u80bf\u7624\u60a3\u8005\uff0c\u9996\u9009\u6574\u86cb\u767d\u914d\u65b9\uff3b41\uff3d\u3002\u81ea\u5236\u5300\u6d46\u81b3\u8425\u517b\u4e0d\u5747\u8861\uff0c\u4fdd\u8d28\u671f\u77ed\uff0c\u53ef\u80fd\u5b58\u5728\u66f4\u9ad8\u7684\u5fae\u751f\u7269\u6c61\u67d3\u98ce\u9669\uff0c\u4e0d\u4f5c\u4e3a\u5e38\u89c4\u63a8\u8350\uff3b41\uff0c48\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c17\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u80a0\u529f\u80fd\u4e25\u91cd\u53d7\u635f\uff0c\u53ef\u9009\u62e9\u8981\u7d20\u578b\u914d\u65b9ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a97.4%\uff09\u3002<\/p>\n
\u8981\u7d20\u578b\u914d\u65b9\u4e3b\u8981\u662f\u6c28\u57fa\u9178\u6216\u77ed\u80bd\u7c7b\u5236\u5242\uff0c\u6210\u5206\u660e\u786e\uff0c\u65e0\u9700\u6d88\u5316\u5373\u53ef\u76f4\u63a5\u5438\u6536\uff0c\u4e0d\u542b\u6b8b\u6e23\uff0c\u9002\u7528\u4e8e\u80c3\u80a0\u9053\u6d88\u5316\u548c\u5438\u6536\u529f\u80fd\u90e8\u5206\u53d7\u635f\u3001\u5b58\u5728\u80a0\u529f\u80fd\u8870\u7aed\u7684\u60a3\u8005\uff3b49\uff3d\uff0c\u4f46\u53e3\u611f\u7a0d\u5dee\uff3b50\uff3d\u3002\u5bf9\u4e8e\u80a0\u529f\u80fd\u65e0\u4e25\u91cd\u635f\u5bb3\u7684\u60a3\u8005\uff0c\u8981\u7d20\u914d\u65b9\u548c\u6574\u86cb\u767d\u914d\u65b9\u5728\u80c3\u80a0\u9053\u8010\u53d7\u6027\u3001\u5e76\u53d1\u75c7\u7b49\u65b9\u9762\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49\uff3b51-52\uff3d\u3002\u5982\u5b58\u5728\u80a0\u529f\u80fd\u8870\u7aed\u3001\u6d88\u5316\u529f\u80fd\u4e25\u91cd\u53d7\u635f\u6216\u5438\u6536\u529f\u80fd\u969c\u788d\uff0c\u5982\u5e7f\u6cdb\u80a0\u5207\u9664\u3001\u77ed\u80a0\u7efc\u5408\u5f81\u7b49\u7684\u80bf\u7624\u60a3\u8005\uff0c\u53ef\u9009\u62e9\u6613\u5438\u6536\u7684\u8981\u7d20\u578b\u914d\u65b9\uff3b53-54\uff3d\u3002\u5bf9\u4e8e\u5408\u5e76\u5371\u91cd\u75c7\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u6301\u7eed\u8179\u6cfb\u6216\u5438\u6536\u4e0d\u826f\uff0c\u4e5f\u53ef\u4ee5\u91c7\u7528\u77ed\u80bd\u914d\u65b9\uff3b26\uff3d\u3002\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u6162\u6027\u80f0\u817a\u708e\uff0c\u4e14\u6807\u51c6\u914d\u65b9\u4e0d\u8010\u53d7\uff0cONS\u53ef\u4ee5\u9009\u62e9\u8981\u7d20\u578b\u914d\u65b9\uff3b46\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c18\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5408\u5e76\u7cd6\u5c3f\u75c5\u6216\u7cd6\u8010\u91cf\u5f02\u5e38\uff0c\u53ef\u9009\u62e9\u7cd6\u5c3f\u75c5\u4e13\u7528\u914d\u65b9\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
\u7ea618%\u80bf\u7624\u60a3\u8005\u4f34\u6709\u7cd6\u5c3f\u75c5\u6216\u8840\u7cd6\u5f02\u5e38\uff3b55\uff3d\uff0c\u800c\u90e8\u5206\u80bf\u7624\u60a3\u8005\u5728\u63a5\u53d7\u6297\u80bf\u7624\u6cbb\u7597\u671f\u95f4\u53ef\u80fd\u4f1a\u51fa\u73b0\u4e0e\u6cbb\u7597\u76f8\u5173\u7684\u8840\u7cd6\u5347\u9ad8\u3002\u8840\u7cd6\u63a7\u5236\u6b20\u4f73\u4f1a\u5f71\u54cd\u5230\u80bf\u7624\u7684\u6cbb\u7597\u6548\u679c\uff0c\u80bf\u7624\u60a3\u8005\u5408\u5e76\u7cd6\u5c3f\u75c5\u53ef\u5347\u9ad8\u6b7b\u4ea1\u7387\uff3b56-57\uff3d\u3002\u5bf9\u5408\u5e76\u7cd6\u5c3f\u75c5\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u8425\u517b\u98ce\u9669\uff0c\u53ef\u9009\u62e9\u7cd6\u5c3f\u75c5\u4e13\u7528\u914d\u65b9ONS\u3002\u8be5\u914d\u65b9\u540c\u666e\u901a\u914d\u65b9\u76f8\u6bd4\uff0c\u5229\u4e8e\u7cd6\u5c3f\u75c5\u60a3\u8005\u7684\u8840\u7cd6\u63a7\u5236\uff3b58-59\uff3d\uff0c\u4e14\u8282\u7701\u533b\u7597\u8d39\u7528\uff3b60\uff3d\u3002\u5bf9\u4e8e\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u80f0\u5c9b\u7d20\u62b5\u6297\uff0cONS\u53ef\u589e\u52a0\u8102\u80aa\u4e0e\u78b3\u6c34\u5316\u5408\u7269\u4f9b\u80fd\u6bd4\uff0c\u4ee5\u964d\u4f4e\u8840\u7cd6\u8d1f\u8377\uff3b3\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c19\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5408\u5e76\u6162\u6027\u80be\u529f\u80fd\u4e0d\u5168\uff08chronic kidney disease\uff0cCKD\uff09\uff0c\u4e14\u5b58\u5728\u4e25\u91cd\u7684\u7535\u89e3\u8d28\u5f02\u5e38\uff0c\u53ef\u9009\u62e9\u7279\u6b8a\u914d\u65b9\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
CKD\u662f\u80bf\u7624\u60a3\u8005\u751f\u5b58\u7684\u72ec\u7acb\u5371\u9669\u56e0\u7d20\uff3b61\uff3d\u3002\u5728\u6297\u80bf\u7624\u6cbb\u7597\u671f\u95f4\uff0c\u60a3\u8005\u80be\u529f\u80fd\u53ef\u80fd\u4f1a\u9010\u6e10\u4e0b\u964d\u3002CKD\u4f1a\u5f71\u54cd\u67d0\u4e9b\u80bf\u7624\u7684\u6cbb\u7597\u9009\u62e9\u3001\u6cbb\u7597\u6548\u679c\u548c\u603b\u4f53\u751f\u5b58\u7387\uff3b62-63\uff3d\u3002CKD\u60a3\u8005\u53ef\u80fd\u5b58\u5728\u4e25\u91cd\u7684\u7535\u89e3\u8d28\u7d0a\u4e71\uff08\u9ad8\u94be\u8840\u75c7\u548c\u9ad8\u78f7\u8840\u75c7\uff09\uff3b64\uff3d\u3002\u6709\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5408\u5e76\u6162\u6027\u80be\u529f\u80fd\u4e0d\u5168\uff0c\u5b58\u5728\u4e25\u91cd\u7684\u7535\u89e3\u8d28\u5f02\u5e38\uff0c\u53ef\u4ee5\u8003\u8651\u9009\u62e9\u94a0\u3001\u94be\u548c\u78f7\u542b\u91cf\u90fd\u8f83\u4f4e\u7684\u4e13\u7528\u914d\u65b9\uff3b65\uff3d\u3002<\/p>\n
\u80be\u529f\u80fd\u4e0d\u5168\u65f6\uff0c\u86cb\u767d\u8d28\u4ee3\u8c22\u4ea7\u7269\u6392\u6cc4\u969c\u788d\u3002\u86cb\u767d\u8d28\u7684\u63a8\u8350\u6444\u5165\u91cf\u65e2\u53d6\u51b3\u4e8eCKD\u5206\u671f\uff0c\u662f\u5426\u80be\u810f\u66ff\u4ee3\u6cbb\u7597\uff0c\u8fd8\u8981\u8003\u8651\u4ee3\u8c22\u72b6\u6001\uff0c\u662f\u5426\u5408\u5e76\u7cd6\u5c3f\u75c5\u53ca\u8840\u7cd6\u63a7\u5236\u60c5\u51b5\u7b49\uff3b64\uff0c66\uff3d\u3002\u5bf9\u4e8e\u5408\u5e76\u80be\u529f\u80fd\u4e0d\u5168\u7684\u80bf\u7624\u60a3\u8005\uff0c\u53ef\u4ee5\u6309\u7167\u80be\u810f\u75be\u75c5\u8425\u517b\u6307\u5357\uff0c\u5236\u5b9a\u5408\u9002\u7684\u86cb\u767d\u8d28\u6444\u5165\u76ee\u6807\u548c\u5145\u8db3\u7684\u80fd\u91cf\u6444\u5165\u76ee\u6807\uff3b64\uff0c66-67\uff3d\u3002<\/p>\n
\u9700\u5f3a\u8c03\u7684\u662f\uff0c\u6b27\u6d32\u80a0\u5916\u80a0\u5185\u8425\u517b\u5b66\u4f1a\u548c\u7f8e\u56fd\u80a0\u5916\u80a0\u5185\u8425\u517b\u5b66\u4f1a\u6307\u5357\u5747\u660e\u786e\u6307\u51fa\uff0c\u5bf9\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80be\u529f\u80fd\u5f02\u5e38\u60a3\u8005\uff0c\u4e0d\u5e38\u89c4\u63a8\u8350\u4f7f\u7528\u9488\u5bf9\u7279\u5b9a\u75be\u75c5\u7684ONS\u914d\u65b9\uff0c\u800c\u5e94\u6839\u636e\u60a3\u8005\u5177\u4f53\u60c5\u51b5\u8fdb\u884c\u4e2a\u4f53\u5316\u6cbb\u7597\u3002\u53ea\u6709\u5b58\u5728\u4e25\u91cd\u7684\u7535\u89e3\u8d28\u5f02\u5e38\uff0c\u53ef\u8003\u8651\u9009\u62e9\u94a0\u3001\u94be\u548c\u78f7\u542b\u91cf\u90fd\u8f83\u4f4e\u7684\u4e13\u7528\u914d\u65b9\uff3b26\uff0c66\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c110\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u9700\u8981\u9650\u5236\u5165\u91cf\uff0c\u53ef\u9009\u62e9\u9ad8\u80fd\u91cf\u5bc6\u5ea6\u914d\u65b9ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a94.7%\uff09\u3002<\/p>\n
\u80bf\u7624\u60a3\u8005\u5e38\u5b58\u5728\u9ad8\u4ee3\u8c22\u72b6\u6001\uff0c\u5e94\u4fdd\u8bc1\u5145\u8db3\u7684\u80fd\u91cf\u6444\u5165\u3002\u5bf9\u9700\u4e25\u683c\u9650\u5236\u6c34\u5206\u6444\u5165\u7684\u60a3\u8005\uff0c\u53ef\u9009\u62e9\u80fd\u91cf\u5bc6\u5ea6\u9ad8\u7684\u914d\u65b9\uff0c\u5728\u6ee1\u8db3\u80fd\u91cf\u6444\u5165\u7684\u57fa\u7840\u4e0a\uff0c\u51cf\u5c11\u6db2\u4f53\u8d1f\u8377\u3002\u5f53\u80bf\u7624\u60a3\u8005\u5408\u5e76\u5371\u91cd\u75c7\u60c5\u51b5\uff0c\u5728\u6025\u6027\u547c\u5438\u7cfb\u7edf\u8870\u7aed\u65e9\u671f\uff0c\u53ef\u9009\u62e9\u9ad8\u80fd\u91cf\u5bc6\u5ea6\u548c\u9ad8\u86cb\u767d\u914d\u65b9\uff3b26\uff0c68\uff3d\u3002\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u4f4e\u86cb\u767d\u8840\u75c7\uff0c\u4e14\u65e0\u4e25\u91cd\u7684\u80be\u529f\u80fd\u5f02\u5e38\uff0c\u53ef\u914c\u60c5\u9009\u62e9\u9ad8\u86cb\u767dONS\u3002\u5bf9\u5408\u5e76\u91cd\u5ea6\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u708e\u7684\u80bf\u7624\u60a3\u8005\uff0c\u53ef\u9009\u62e9\u9ad8\u80fd\u91cf\u5bc6\u5ea6\u914d\u65b9\uff3b69\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c111\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u62df\u63a5\u53d7\u5927\u624b\u672f\uff0cONS\u9009\u62e9\u514d\u75ab\u589e\u5f3a\u914d\u65b9\u53ef\u80fd\u83b7\u76ca\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u9ad8\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
\u514d\u75ab\u589e\u5f3a\u578b\u914d\u65b9\u4e2d\u6dfb\u52a0\u4e86\u5982\u8c37\u6c28\u9170\u80fa\u3001\u7cbe\u6c28\u9178\u3001\u6838\u82f7\u9178\u53ca\u03c9-3\u8102\u80aa\u9178\u7b49\u514d\u75ab\u8425\u517b\u7d20\u3002\u5bf9\u6d88\u5316\u9053\u80bf\u7624\u624b\u672f\u60a3\u8005\u7684\u4e34\u5e8a\u7814\u7a76\u53d1\u73b0\uff0c\u4e0e\u666e\u901a\u5236\u5242\u6bd4\u8f83\uff0c\u514d\u75ab\u8425\u517b\u5236\u5242\u5177\u6709\u63d0\u9ad8\u673a\u4f53\u514d\u75ab\u529b\u3001\u964d\u4f4e\u611f\u67d3\u6027\u5e76\u53d1\u75c7\u3001\u4fc3\u8fdb\u4f24\u53e3\u6108\u5408\u7b49\u4f5c\u7528\u3002\u4e00\u9879\u7eb3\u516583\u4e2a\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c\u7684\u7cfb\u7edf\u7efc\u8ff0\u6307\u51fa\uff0c\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u56f4\u672f\u671f\u63a5\u53d7\u5305\u542b\u7cbe\u6c28\u9178\u3001\u6838\u9178\u548c\u5fc5\u9700\u8102\u80aa\u9178\u6df7\u5408\u7684\u514d\u75ab\u589e\u5f3a\u578b\u8425\u517b\u652f\u6301\u53ef\u80fd\u53d7\u76ca\uff3b70\uff3d\u3002\u5bf9\u4e8e\u63a5\u53d7\u8179\u90e8\u5927\u624b\u672f\u7684\u80bf\u7624\u60a3\u8005\uff0c\u672f\u540e\u7ed9\u4e88\u514d\u75ab\u589e\u5f3a\u80a0\u5185\u8425\u517b\u53ef\u80fd\u83b7\u76ca\uff3b71\uff3d\u3002\u56e0\u6b64\uff0c\u5bf9\u4e8e\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u62df\u63a5\u53d7\u5927\u624b\u672f\uff0c\u53ef\u9009\u62e9\u514d\u75ab\u589e\u5f3a\u914d\u65b9\uff3b72\uff3d\u3002\u5728\u975e\u56f4\u672f\u671f\u80bf\u7624\u60a3\u8005\u4e2d\uff0c\u514d\u75ab\u589e\u5f3a\u914d\u65b9\u7684\u4e34\u5e8a\u83b7\u76ca\u5c1a\u9700\u66f4\u591a\u8bc1\u636e\uff1b\u5bf9\u4e8e\u5408\u5e76\u5371\u91cd\u75c7\u7b49\u7684\u80bf\u7624\u60a3\u8005\uff0c\u514d\u75ab\u8425\u517b\u7d20\u65e0\u660e\u786e\u83b7\u76ca\u8bc1\u636e\uff3b73\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c112\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u4e0d\u5e38\u89c4\u63a8\u8350\u5f3a\u5316\u03c9-3\u8102\u80aa\u9178\u7684ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a86.9%\uff09\u3002<\/p>\n
\u03c9-3\u8102\u80aa\u9178\u53ef\u51cf\u5c11\u764c\u6027\u6076\u75c5\u8d28\u76f8\u5173\u4fc3\u708e\u6027\u7ec6\u80de\u56e0\u5b50\u751f\u6210\uff3b74\uff3d\u3002\u5bf9\u4e8e\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u6dfb\u52a0\u03c9-3\u8102\u80aa\u9178\u7684ONS\u6709\u52a9\u4e8e\u7ef4\u6301\u4f53\u91cd\uff3b72\uff3d\u3002\u5bf9\u63a5\u53d7\u5316\u7597\u7684\u60a3\u8005\uff0c\u53ef\u4f7f\u7528\u5bcc\u542b\u03c9-3\u8102\u80aa\u9178\u7684ONS\u6539\u5584\u98df\u6b32\uff0c\u7ef4\u6301\u7626\u4f53\u7ec4\u7ec7\uff3b75\uff3d\u3002\u4f46\u5f3a\u5316\u03c9-3\u8102\u80aa\u9178\u7684ONS\u5bf9\u4e8e\u80bf\u7624\u60a3\u8005\u7684\u957f\u671f\u4e34\u5e8a\u83b7\u76ca\u4ecd\u5b58\u5728\u4e89\u8bae\uff3b76\uff3d\uff0c\u5728\u4e00\u9879\u968f\u673a\u5bf9\u7167\u7814\u7a76\u4e2d\uff0c\u540c\u6807\u51c6\u914d\u65b9\u76f8\u6bd4\uff0c\u5bcc\u542b\u03c9-3\u8102\u80aa\u9178\u7684\u914d\u65b9\u867d\u53ef\u6539\u5584\u8425\u517b\u8bc4\u5206\uff0c\u4f46\u672a\u663e\u8457\u6539\u5584\u63a5\u53d7\u653e\u7597\u7684\u5934\u9888\u90e8\u80bf\u7624\u6216\u98df\u7ba1\u80bf\u7624\u60a3\u8005\u7684\u7626\u4f53\u7ec4\u7ec7\uff3b77\uff3d\u3002\u5728\u8fdb\u5c55\u671f\u80bf\u7624\u60a3\u8005\u4e2d\u4f7f\u7528\u03c9-3\u8102\u80aa\u9178\u5e76\u4e0d\u4f1a\u5ef6\u957f\u751f\u5b58\u671f\uff3b3\uff3d\u3002\u80bf\u7624\u60a3\u8005\u5408\u5e76\u5371\u91cd\u75c7\uff0c\u53ef\u9009\u62e9\u542b\u6b63\u5e38\u5242\u91cf\u03c9-3\u8102\u80aa\u9178\u7684ONS\uff0c\u800c\u4e0d\u5e38\u89c4\u4f7f\u7528\u5f3a\u5316\u03c9-3\u8102\u80aa\u9178\u7684ONS\uff3b27\uff3d\u3002\u80bf\u7624\u60a3\u8005\u5982\u5b58\u5728\u6025\u6027\u80ba\u635f\u4f24\u3001\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u548c\u91cd\u5ea6\u83cc\u8840\u75c7\uff0c\u4f7f\u7528\u9ad8\u5242\u91cf\u03c9-3\u8102\u80aa\u9178\u7684ONS\u5c1a\u5b58\u5728\u4e89\u8bae\uff3b26\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c113\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u4e0d\u5e38\u89c4\u63a8\u8350\u5f3a\u5316\u03b2-\u7f9f\u57fa-\u03b2-\u4e01\u9178\u7532\u916f\uff08beta-hydroxy-beta-methylbutyrate\uff0cHMB\uff09\u7684ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a92.1%\uff09\u3002<\/p>\n
HMB\u53ef\u6539\u5584\u808c\u5c11\u75c7\u60a3\u8005\u7684\u708e\u6027\u6307\u6807\u3001\u808c\u8089\u529b\u91cf\u548c\u751f\u6d3b\u8d28\u91cf\uff3b78\uff3d\u3002\u7814\u7a76\u53d1\u73b0\uff0c\u6bcf\u5929\u6444\u51653 gHMB\uff0c\u5e72\u988410 d\uff5e24\u5468\uff0c\u65e0\u4e25\u91cd\u5e76\u53d1\u75c7\u53d1\u751f\uff3b79\uff3d\u3002\u5bf9\u5b58\u5728\u538b\u75ae\u7684\u5171\u75c5\u60a3\u8005\uff0c\u7ed9\u4e88\u542b\u6709HMB\u7684ONS\u6709\u52a9\u4e8e\u538b\u75ae\u7684\u6cbb\u7597\uff3b7\uff3d\u3002\u7ed9\u4e88\u542bHMB\u7684ONS10 d\uff5e24\u5468\u540e\uff0c\u53ef\u6539\u5584\u808c\u5c11\u75c7\u60a3\u8005\u7684\u708e\u6027\u6307\u6807\u3001\u63e1\u529b\u548c\u751f\u6d3b\u8d28\u91cf\uff3b80-81\uff3d\uff0c\u4f46\u5728\u9488\u5bf9\u80bf\u7624\u60a3\u8005\u7684\u957f\u671f\u968f\u673a\u5bf9\u7167\u7814\u7a76\u4e2d\uff0cHMB\u7684\u4e34\u5e8a\u83b7\u76ca\u5c1a\u4e0d\u660e\u786e\uff0c\u9700\u66f4\u591a\u7814\u7a76\u8bc1\u5b9e\uff3b25\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c114\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u4e0d\u5e38\u89c4\u63a8\u8350\u5f3a\u5316\u7cbe\u6c28\u9178\u7684ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a97.4%\uff09\u3002<\/p>\n
\u7cbe\u6c28\u9178\u662f\u4e00\u79cd\u7ef4\u62a4\u673a\u4f53\u6b63\u5e38\u514d\u75ab\u529f\u80fd\u548c\u6108\u5408\u7684\u514d\u75ab\u8425\u517b\u7d20\uff0c\u7cbe\u6c28\u9178\u7f3a\u4e4f\uff0c\u6b63\u5e38\u514d\u75ab\u529f\u80fd\u53d7\u5230\u5f71\u54cd\uff0c\u6613\u589e\u52a0\u75be\u75c5\u6613\u611f\u6027\uff3b82-83\uff3d\u3002\u7cbe\u6c28\u9178\u7684\u5f3a\u5316\u5e94\u7528\u4ecd\u5b58\u5728\u4e89\u8bae\u3002\u5bf9\u4e8e\u5b58\u5728\u538b\u75ae\u3001\u6709\u8425\u517b\u98ce\u9669\u7684\u60a3\u8005\uff0c\u7ed9\u4e88\u542b\u6709\u7cbe\u6c28\u9178\u7684ONS\u6709\u52a9\u4e8e\u538b\u75ae\u7684\u6cbb\u7597\uff3b7\uff3d\u3002\u4e00\u9879\u5c0f\u6837\u672c\u77ed\u671f\u5e72\u9884\u7814\u7a76\u53d1\u73b0\uff0c\u4f7f\u7528\u5f3a\u5316\u7cbe\u6c28\u9178\u7684\u80a0\u5185\u8425\u517b\u6709\u52a9\u4e8e\u6539\u5584\u60a3\u8005\u6c2e\u5e73\u8861\uff3b84\uff3d\uff0c\u4f46\u5bf9\u4e8e\u80bf\u7624\u60a3\u8005\uff0c\u5c1a\u65e0\u660e\u786e\u8bc1\u636e\u663e\u793a\u4f7f\u7528\u5f3a\u5316\u7cbe\u6c28\u9178ONS\u53ef\u4e34\u5e8a\u83b7\u76ca\u3002<\/p>\n
\u63a8\u8350\u610f\u89c115\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u4e0d\u5e38\u89c4\u63a8\u8350\u5f3a\u5316\u8c37\u6c28\u9170\u80fa\u7684ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a94.7%\uff09\u3002<\/p>\n
\u76ee\u524d\u7814\u7a76\u8bc1\u636e\u53d1\u73b0\uff0c\u5bf9\u63a5\u53d7\u653e\u7597\u7684\u80bf\u7624\u60a3\u8005\uff0c\u4e0d\u5e38\u89c4\u63a8\u8350\u5e94\u7528\u8c37\u6c28\u9170\u80fa\u9884\u9632\u8f90\u5c04\u5f15\u8d77\u7684\u80a0\u708e\/\u8179\u6cfb\u3001\u53e3\u8154\u708e\u3001\u98df\u7ba1\u708e\u6216\u76ae\u80a4\u6bd2\u6027\uff3b3\uff3d\u3002\u5bf9\u4e8e\u63a5\u53d7\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u7684\u60a3\u8005\uff0c\u6ca1\u6709\u8db3\u591f\u4e00\u81f4\u7684\u4e34\u5e8a\u8bc1\u636e\u63a8\u8350\u8c37\u6c28\u9170\u80fa\u6539\u5584\u9ad8\u5242\u91cf\u5316\u7597\u548c\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u60a3\u8005\u7684\u4e34\u5e8a\u7ed3\u5c40\uff3b3\uff0c25\uff3d\u3002\u5b58\u5728\u70e7\u4f24\u548c\u521b\u4f24\u7684\u80bf\u7624\u60a3\u8005\uff0c\u53ef\u8865\u5145\u542b\u8c37\u6c28\u9170\u80fa\uff3b0.2\uff5e0.3 g\/\uff08kg\u00b7d\uff09\uff3d\u7684ONS\uff3b26\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c116\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u80f0\u817a\u5916\u5206\u6ccc\u529f\u80fd\u4e0d\u5168\uff0c\u8865\u5145\u80f0\u9176\u548c\u6392\u9664\u7ec6\u83cc\u8fc7\u5ea6\u751f\u957f\u540e\uff0c\u6d88\u5316\u4e0d\u826f\u75c7\u72b6\u4ecd\u4e0d\u80fd\u6709\u6548\u7f13\u89e3\uff0c\u53ef\u9009\u62e9\u5bcc\u542b\u4e2d\u94fe\u7518\u6cb9\u4e09\u916f\uff08medium-chain triglyceride\uff0cMCT\uff09\u7684\u8981\u7d20ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a97.4%\uff09\u3002<\/p>\n
\u63a5\u53d7\u80f0\u5341\u4e8c\u6307\u80a0\u5207\u9664\u672f\u540e\u7684\u80bf\u7624\u60a3\u8005\u53ef\u80fd\u5b58\u5728\u80f0\u817a\u5916\u5206\u6ccc\u529f\u80fd\u4e0d\u5168\uff3b85\uff3d\u3002\u5728\u8865\u5145\u80f0\u9176\u6cbb\u7597\u7684\u57fa\u7840\u4e0a\uff0c\u9009\u62e9\u5bcc\u542bMCT\u7684ONS\uff0c\u53ef\u80fd\u6709\u5229\u4e8e\u80f0\u817a\u5207\u9664\u672f\u540e\u6216\u5408\u5e76\u6162\u6027\u80f0\u817a\u708e\u7b49\u80f0\u817a\u5916\u5206\u6ccc\u529f\u80fd\u4e0d\u5168\u7684\u60a3\u8005\u3002\u4e00\u9879\u968f\u673a\u5bf9\u7167\u7814\u7a76\u4e2d\uff0c60\u4f8b\u6162\u6027\u80f0\u817a\u708e\u60a3\u8005\uff0c\u5728\u63a5\u53d7\u80f0\u9176\u8865\u5145\u57fa\u7840\u4e0a\uff0c\u63a5\u53d7\u5355\u7eaf\u996e\u98df\u6307\u5bfc\u6216\u5bcc\u542bMCT\u7684ONS\u5e72\u98843\u4e2a\u6708\u540e\uff0c\u4e24\u7ec4\u5728\u996e\u98df\u6444\u5165\u548c\u7caa\u4fbf\u8102\u80aa\u91cf\u7b49\u65b9\u9762\u5747\u6709\u6240\u6539\u5584\uff0c\u4f46\u4e8c\u8005\u6bd4\u8f83\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49\uff3b86\uff3d\u3002\u56e0\u6b64\uff0c\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u6162\u6027\u80f0\u817a\u708e\u60a3\u8005\u5728\u8865\u5145\u8db3\u591f\u80f0\u9176\u548c\u6392\u9664\u7ec6\u83cc\u8fc7\u5ea6\u751f\u957f\u540e\uff0c\u4ecd\u672a\u80fd\u7f13\u89e3\u6d88\u5316\u4e0d\u826f\u4f34\u968f\u75c7\u72b6\uff0c\u53ef\u9009\u62e9\u5bcc\u542bMCT\u7684ONS\uff3b46\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c117\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0cONS\u4e0d\u5e38\u89c4\u63a8\u8350\u5f3a\u5316\u652f\u94fe\u6c28\u57fa\u9178\uff08branched-chain amino acids\uff0cBCAA\uff09\u7684ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a92.1%\uff09\u3002<\/p>\n
\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u809d\u810f\u80bf\u7624\u60a3\u8005\uff0c\u4f7f\u7528BCAA\u7684ONS\u5e76\u4e0d\u80fd\u964d\u4f4e\u6b7b\u4ea1\u7387\uff3b44\uff3d\u3002\u80bf\u7624\u60a3\u8005\u5982\u5408\u5e76\u809d\u6027\u8111\u75c5\uff0c\u53ef\u9009\u62e9\u5bcc\u542bBCAA\u7684\u914d\u65b9\uff3b26\uff3d\u3002\u4e00\u9879\u7eb3\u516516\u9879\u8bd5\u9a8c\u3001\u5171827\u4f8b\u809d\u6027\u8111\u75c5\u60a3\u8005\u7684\u835f\u8403\u5206\u6790\u8bc4\u4f30\u4e86BCAA\u7684\u7597\u6548\uff1b\u7ed3\u679c\u663e\u793a\uff0cBCAA\u5e76\u672a\u964d\u4f4e\u6b7b\u4ea1\u7387\uff08RR 0.8\uff0c95%CI 0.7\uff5e1.1\uff09\uff0c\u4f46\u53ef\u80fd\u5229\u4e8e\u809d\u6027\u8111\u75c5\u75c7\u72b6\u6539\u5584\uff08RR 0.7\uff0c95%CI 0.6\uff5e0.9\uff09\uff3b87\uff3d\u3002\u4e00\u9879\u7eb3\u5165116\u4f8b\u65e2\u5f80\u6709\u809d\u6027\u8111\u75c5\u53d1\u4f5c\u60a3\u8005\u7684\u968f\u673a\u8bd5\u9a8c\u53d1\u73b0\uff0cBCAA\u5bf9\u590d\u53d1\u6027\u809d\u6027\u8111\u75c5\u65e0\u76ca\uff3b88\uff3d\u3002\u901a\u5e38\uff0c\u53ea\u6709\u63a5\u53d7\u8fc7\u95e8\u4f53\u5206\u6d41\u672f\u7684\u60a3\u8005\uff0c\u5176\u809d\u6027\u8111\u75c5\u624d\u4f1a\u5728\u9650\u5236\u86cb\u767d\u7684\u57fa\u7840\u4e0a\u8865\u5145BCAA\u3002\u5bf9\u4e8e\u5b58\u5728\u8425\u517b\u98ce\u9669\u4e14\u5408\u5e76\u808c\u5c11\u75c7\u6216\u6076\u75c5\u8d28\u7684\u80bf\u7624\u60a3\u8005\uff0c\u8865\u5145\u5bcc\u542b\u4eae\u6c28\u9178\u7684\u652f\u94fe\u6c28\u57fa\u9178\u53ef\u80fd\u6539\u5584\u808c\u8089\u91cf\uff0c\u4f46\u5c1a\u9700\u66f4\u591a\u7814\u7a76\u8fdb\u4e00\u6b65\u9a8c\u8bc1\uff3b89\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c118\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u8179\u6cfb\u6216\u4fbf\u79d8\uff0c\u53ef\u9009\u62e9\u542b\u6709\u81b3\u98df\u7ea4\u7ef4\u7684ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a97.4%\uff09\u3002<\/p>\n
\u57fa\u4e8e\u76ee\u524d\u8bc1\u636e\uff0c\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5408\u5e76\u8179\u6cfb\uff0c\u53ef\u5e38\u89c4\u4f7f\u7528\u542b\u81b3\u98df\u7ea4\u7ef4\u914d\u65b9\u7684ONS\u3002\u5982\u5408\u5e76\u4fbf\u79d8\uff0c\u53ef\u4f7f\u7528\u542b\u81b3\u98df\u7ea4\u7ef4\u914d\u65b9\uff3b48\uff3d\u3002\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u8001\u5e74\u80bf\u7624\u60a3\u8005\uff0c\u53ef\u4f7f\u7528\u542b\u81b3\u98df\u7ea4\u7ef4\u914d\u65b9\uff3b45\uff3d\u3002\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5408\u5e76\u5371\u91cd\u75c7\uff0c\u4e0d\u5e38\u89c4\u63a8\u8350\u5bcc\u542b\u81b3\u98df\u7ea4\u7ef4\u7684\u5236\u5242\u4ee5\u9884\u9632\u8179\u6cfb\u6216\u4fbf\u79d8\uff1b\u5982\u5b58\u5728\u80a0\u7f3a\u8840\u548c\u91cd\u5ea6\u80a0\u9053\u529f\u80fd\u969c\u788d\uff0c\u4e0d\u63a8\u8350\u4f7f\u7528\u5bcc\u542b\u81b3\u98df\u7ea4\u7ef4\u914d\u65b9\uff1b\u5bf9\u4e8e\u96be\u6cbb\u6027\u8179\u6cfb\uff0c\u53ef\u4f7f\u7528\u81b3\u98df\u7ea4\u7ef4\u914d\u65b9\uff3b26\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c119\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u4e0d\u5e38\u89c4\u63a8\u8350\u76ca\u751f\u83cc\u8054\u5408ONS\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a89.4%\uff09\u3002<\/p>\n
\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u63a5\u53d7\u653e\u7597\u540e\uff0c\u6ca1\u6709\u8db3\u591f\u4e00\u81f4\u7684\u4e34\u5e8a\u6570\u636e\u63a8\u8350\u76ca\u751f\u83cc\u6765\u51cf\u5c11\u8f90\u5c04\u5f15\u8d77\u7684\u8179\u6cfb\uff3b3\uff3d\u3002\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u5b58\u5728\u5371\u91cd\u75c7\uff0c\u4f7f\u7528\u76ca\u751f\u83cc\u65e0\u4e34\u5e8a\u83b7\u76ca\u8bc1\u636e\uff3b73\uff3d\u3002\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u5408\u5e76\u80f0\u817a\u708e\u7684\u80bf\u7624\u60a3\u8005\uff0c\u4e0d\u5e38\u89c4\u63a8\u8350\u4f7f\u7528\u76ca\u751f\u83cc\uff3b46\uff3d\u3002\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u809d\u79fb\u690d\u672f\u540e\u53ef\u4f7f\u7528\u76ca\u751f\u83cc\u8054\u5408ONS\uff3b44\uff3d\u3002<\/p>\n
\u63a8\u8350\u610f\u89c120\uff1a\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\u91c7\u7528ONS\uff0c\u5e94\u76d1\u6d4b\u8425\u517b\u652f\u6301\u6cbb\u7597\u7684\u6548\u679c\u548c\u5e76\u53d1\u75c7\uff08\u8bc1\u636e\u7ea7\u522b\uff1a\u4f4e\uff0c\u63a8\u8350\u5f3a\u5ea6\uff1a\u5f3a\uff0c\u8d5e\u540c\u7387\uff1a100%\uff09\u3002<\/p>\n
\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u63a5\u53d7ONS\u540e\u5e94\u6ce8\u610f\u76d1\u6d4b\u8425\u517b\u6cbb\u7597\u7684\u6548\u679c\u548c\u5e76\u53d1\u75c7\u3002\u5982ONS\u6301\u7eed\u4e0d\u80fd\u6ee1\u8db3\u60a3\u8005\u80fd\u91cf\u548c\u86cb\u767d\u8d28\u9700\u6c42\uff0c\u9700\u8003\u8651\u7ba1\u9972\u80a0\u5185\u8425\u517b\uff08\u5e7d\u95e8\u524d\u3001\u540e\u5582\u517b\uff0c\u7ecf\u9f3b\u6216\u7ecf\u6d88\u5316\u9053\u7f6e\u7ba1\u7b49\uff09\u6216\u80a0\u5916\u8425\u517b\uff3b9\uff0c16\uff3d\u3002\u8fd8\u5e94\u76d1\u6d4b\u809d\u529f\u80fd\u3001\u80be\u529f\u80fd\u3001\u8840\u7cd6\u548c\u8840\u8102\uff1b\u76d1\u6d4b\u8179\u6cfb\u3001\u8179\u80c0\uff1b\u76d1\u6d4b\u80fd\u91cf\u3001\u86cb\u767d\u6444\u5165\u91cf\u3001\u5fae\u91cf\u8425\u517b\u7d20\u6444\u5165\u7b49\uff1b\u957f\u671f\u6162\u6027\u6d88\u8017\u8005\u5e94\u5bc6\u5207\u76d1\u6d4b\u8840\u6e05\u78f7\u3001\u9541\u548c\u7ef4\u751f\u7d20B1\u6c34\u5e73\uff0c\u4ee5\u9884\u9632\u518d\u5582\u517b\u7efc\u5408\u5f81\uff3b29\uff3d\u3002<\/p>\n
5 \u7ed3\u8bed<\/p>\n
\u80bf\u7624\u60a3\u8005\u5e38\u4f34\u8425\u517b\u98ce\u9669\/\u8425\u517b\u4e0d\u826f\u3002\u5408\u7406\u7684\u8425\u517b\u652f\u6301\u6cbb\u7597\u6709\u52a9\u4e8e\u80bf\u7624\u60a3\u8005\u7ef4\u6301\u7626\u4f53\u91cd\uff0c\u6539\u5584\u4e34\u5e8a\u7ed3\u5c40\u548c\u751f\u6d3b\u8d28\u91cf\uff3b89\uff3d\u3002\u5df2\u5b58\u5728\u8425\u517b\u98ce\u9669\u7684\u80bf\u7624\u60a3\u8005\uff0c\u5982\u80c3\u80a0\u9053\u529f\u80fd\u5141\u8bb8\uff0c\u5e94\u65e9\u671fONS\u3002\u80bf\u7624\u60a3\u8005\u9009\u62e9\u5408\u7406\u7684ONS\uff0c\u5e94\u5728\u9075\u5faa\u8425\u517b\u8bca\u7597\u6d41\u7a0b\u7684\u57fa\u7840\u4e0a\uff0c\u7ed3\u5408\u80bf\u7624\u60a3\u8005\u7684\u75c5\u60c5\u7279\u70b9\uff0c\u56e0\u5730\u5236\u5b9c\uff0c\u5408\u7406\u89c4\u8303\u5730\u5b9e\u65bd\uff0c\u4e14\u4e25\u5bc6\u76d1\u6d4b\u548c\u53ca\u65f6\u8c03\u6574\uff0c\u5c3d\u91cf\u907f\u514d\u6216\u51cf\u5c11\u5e76\u53d1\u75c7\u7684\u53d1\u751f\uff0c\u4f7f\u80bf\u7624\u60a3\u8005\u83b7\u76ca\u3002<\/p>\n
\u53c2\u4e0e\u7f16\u5199\u53ca\u5ba1\u6838\u4e13\u5bb6\uff08\u6309\u59d3\u6c0f\u62fc\u97f3\u6392\u5e8f\uff09\uff1a\u9648\u9122\u6d25\uff08\u5929\u6d25\u5e02\u5357\u5f00\u533b\u9662\uff09\uff1b\u9648\u6d01\u6587\uff08\u4e0a\u6d77\u4ea4\u5927\u533b\u5b66\u9662\u9644\u5c5e\u7b2c\u4e5d\u4eba\u6c11\u533b\u9662\uff09\uff1b\u4e1b\u660e\u534e\uff08\u4e2d\u56fd\u533b\u5b66\u79d1\u5b66\u9662\u80bf\u7624\u533b\u9662\uff09\uff1b\u7a0b\u632f\u5029\uff08\u5c71\u4e1c\u7b2c\u4e00\u533b\u79d1\u5927\u5b66\u7b2c\u4e00\u9644\u5c5e\u533b\u9662\uff09\uff1b\u7aa6\u6500\uff08\u5317\u5927\u533b\u9662\uff09\uff1b\u65b9\u7389\uff08\u5317\u4eac\u5927\u5b66\u80bf\u7624\u533b\u9662\uff09\uff1b\u623f\u7231\u840d\uff08\u4e2d\u5c71\u5927\u5b66\uff09\uff1b\u9ad8\u6dd1\u6e05\uff08\u6cb3\u5317\u533b\u79d1\u5927\u5b66\u7b2c\u56db\u533b\u9662\uff09\uff1b\u97e9\u78ca\uff08\u9752\u5c9b\u5927\u5b66\u9644\u5c5e\u533b\u9662\uff09\uff1b\u848b\u5fd7\u96c4\uff08\u5e7f\u897f\u533b\u79d1\u5927\u5b66\u7b2c\u4e8c\u9644\u5c5e\u533b\u9662\uff09\uff1b\u5eb7\u519b\u4ec1\uff08\u5317\u4eac\u534f\u548c\u533b\u9662\uff09\uff1b\u5b54\u6c38\u971e\uff08\u6cb3\u5357\u7701\u80bf\u7624\u533b\u9662\uff09\uff1b\u5218\u82f1\u534e\uff08\u89e3\u653e\u519b\u603b\u533b\u9662\uff09\uff1b\u5218\u654f\uff08\u4e2d\u5357\u5927\u5b66\u6e58\u96c5\u4e09\u533b\u9662\uff09\uff1b\u5218\u9e4f\u4e3e\uff08\u5317\u4eac\u534f\u548c\u533b\u9662\uff09\uff1b\u5218\u83ca\u82f1\uff08\u6e58\u96c5\u533b\u9662\uff09\uff1b\u674e\u5b81\uff08\u5317\u4eac\u534f\u548c\u533b\u9662\uff09\uff1b\u674e\u82cf\u5b9c\uff08\u5b89\u5fbd\u7701\u80bf\u7624\u533b\u9662\uff09\uff1b\u674e\u7d20\u4e91\uff08\u4e2d\u56fd\u533b\u5b66\u79d1\u5b66\u9662\u80bf\u7624\u533b\u9662\uff09\uff1b\u674e\u8389\uff08\u65b0\u7586\u533b\u79d1\u5927\u5b66\u7b2c\u4e00\u9644\u5c5e\u533b\u9662\uff09\uff1b\u674e\u589e\u5b81\uff08\u6cb3\u5317\u533b\u79d1\u5927\u5b66\u7b2c\u4e00\u533b\u9662\uff09\uff1b\u674e\u7136\uff08\u54c8\u5c14\u6ee8\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u7b2c\u4e8c\u533b\u9662\uff09\uff1b\u674e\u82cf\u5b9c\uff08\u4e2d\u56fd\u79d1\u6280\u5927\u5b66\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\uff09\uff1b\u6797\u5e06\uff08\u798f\u5efa\u7701\u7acb\u533b\u9662\uff09\uff1b\u96f7\u65ed\u4e1c\uff08\u7518\u8083\u7701\u80bf\u7624\u533b\u9662\uff09\uff1b\u5b59\u5efa\u7434\uff08\u534e\u4e1c\u533b\u9662\uff09\uff1b\u65bd\u4e07\u82f1\uff08\u4e2d\u56fd\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\uff09\uff1b\u8c2d\u8363\u97f6\uff08\u5e7f\u5dde\u5e02\u7ea2\u5341\u5b57\u4f1a\u533b\u9662\uff09\uff1b\u7ae5\u5e08\u96ef\uff08\u91cd\u5e86\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u7b2c\u4e8c\u533b\u9662\uff09\uff1b\u8c2d\u6842\u519b\uff08\u5929\u6d25\u5e02\u7b2c\u4e00\u4e2d\u5fc3\u533b\u9662\uff09\uff1b\u9676\u5e94\u9f99\uff08\u65b0\u7586\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u80bf\u7624\u533b\u9662\uff09\uff1b\u738b\u4ef2\uff08\u6210\u90fd\u5e02\u7b2c\u4e94\u4eba\u6c11\u533b\u9662\uff09\uff1b\u738b\u5e7f\u73b2\uff08\u6c5f\u897f\u7701\u4eba\u6c11\u533b\u9662\uff09\uff1b\u4e07\u71d5\uff08\u5357\u660c\u5927\u5b66\u7b2c\u4e8c\u9644\u5c5e\u533b\u9662\uff09\uff1b\u8bb8\u6dd1\u82b3\uff08\u6df1\u5733\u524d\u6d77\u6cf0\u5eb7\u533b\u9662\uff09\uff1b\u8f9b\u5b9d\uff08\u9655\u897f\u4e2d\u533b\u5b66\u9662\u516c\u5171\u536b\u751f\u7cfb\uff09\uff1b\u8096\u51e4\u4ed9\uff08\u4fdd\u5b9a\u5e02\u7b2c\u4e8c\u4e2d\u5fc3\u533b\u9662\uff09\uff1b\u4e8e\u5eb7\uff08\u5317\u4eac\u534f\u548c\u533b\u9662\uff09\uff1b\u53f6\u6587\u5cf0\uff08\u4e2d\u5c71\u5927\u5b66\u80bf\u7624\u533b\u9662\uff09\uff1b\u6768\u5251\uff08\u91cd\u5e86\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u7b2c\u4e09\u533b\u9662\uff09\uff1b\u8881\u4f1f\uff08\u4e0a\u6d77\u5e02\u9759\u5b89\u533a\u533a\u57df\u533b\u7597\u4e2d\u5fc3\uff09\uff1b\u95eb\u65b0\u6b23\uff08\u822a\u5929\u4e2d\u5fc3\u533b\u9662\uff09\uff1b\u4f59\u6167\u9752\uff08\u91cd\u5e86\u5927\u5b66\u9644\u5c5e\u80bf\u7624\u533b\u9662\uff09\uff1b\u6731\u7fe0\u51e4\uff08\u5357\u65b9\u533b\u79d1\u5927\u5b66\u6df1\u5733\u533b\u9662\uff09\uff1b\u5f20\u52c7\u80dc\uff08\u5e7f\u897f\u533b\u79d1\u5927\u5b66\u7b2c\u4e00\u9644\u5c5e\u533b\u9662\uff09\uff1b\u5f20\u6653\u4f1f\uff08\u6cb3\u5317\u7701\u4eba\u6c11\u533b\u9662\uff09\uff1b\u7fdf\u5174\u6708\uff08\u5927\u8fde\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u7b2c\u4e8c\u533b\u9662\uff09\uff1b\u8d75\u8d5f\u535a\uff08\u5317\uff09\uff1b\uff08\u4e2d\u56fd\u8425\u517b\u5b66\u4f1a\u80bf\u7624\u8425\u517b\u7ba1\u7406\u5206\u4f1a\uff09<\/p>\n
\u53c2\u8003\u6587\u732e<\/p>\n
[1]Wang F, Zhen HN, Wang HP, et al. Measurement of sarcopenia in lung cancer inpatients and its association with frailty, nutritional risk, and malnutrition[J]. Front Nutr, 2023, 10: 1143213. DOI: 10.3389\/fnut.2023. 1143213.<\/p>\n
[2] \u738b\u65b9, \u4e8e\u5eb7. \u80ba\u764c\u60a3\u8005\u808c\u8089\u72b6\u51b5\u3001\u8425\u517b\u98ce\u9669\u3001\u6076\u75c5\u8d28\u4e0e\u5316\u7597\u8bf1\u5bfc\u6bd2\u6027\u7684\u5173\u7cfb[J]. \u4e2d\u534e\u4e34\u5e8a\u8425\u517b\u6742\u5fd7, 2023, 31(3): 138-145.DOI: 10.3760\/cma.j.cn115822-20230420- 00066.<\/p>\n
[3] Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients[J]. Clin Nutr, 2017, 36(1): 11-48. DOI: 10.1016\/j.clnu.2016.07.015.<\/p>\n
[4] \u674e\u878d\u878d, \u4e8e\u5eb7, \u4e2d\u56fd\u8425\u517b\u5b66\u4f1a\u80bf\u7624\u8425\u517b\u7ba1\u7406\u5206\u4f1a. \u6076\u6027\u80bf\u7624\u60a3\u8005\u5eb7\u590d\u671f\u8425\u517b\u7ba1\u7406\u4e13\u5bb6\u5171\u8bc6(2023\u7248)[J]. \u4e2d\u534e\u4e34\u5e8a\u8425\u517b\u6742\u5fd7, 2023, 31(2): 65-73. DOI: 10.3760\/cma.j.cn115822-20230416-00062.<\/p>\n
[5] Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus[J]. Lancet Oncol, 2011, 12(5): 489-495. DOI: 10.1016\/S1470-2045(10)70218-7.<\/p>\n
[6] \u4e2d\u534e\u533b\u5b66\u4f1a. \u4e34\u5e8a\u8bca\u7597\u6307\u5357\u80a0\u5916\u80a0\u5185\u8425\u517b\u5b66\u5206\u518c[M]. \u5317\u4eac: \u4eba\u6c11\u536b\u751f\u51fa\u7248\u793e, 2008.<\/p>\n
[7] Wunderle C, Gomes F, Schuetz P, et al. ESPEN practical guideline: nutritional support for polymorbid medical inpatients[J]. Clin Nutr, 2024, 43(3): 674-691. DOI: 10.1016\/j.clnu.2024.01.008.<\/p>\n
[8] Wilschanski M, Munck A, Carrion E, et al. Espen-espghan-ECFS guideline on nutrition care for cystic fibrosis[J]. Clin Nutr, 2024, 43(2): 413-445. DOI: 10.1016\/j.clnu.2023.12.017.<\/p>\n
[9] Boullata JI, Carrera AL, Harvey L, et al. ASPEN safe practices for enteral nutrition therapy[formula: see text][J]. JPEN J Parenter Enteral Nutr, 2017, 41(1): 15-103. DOI: 10.1177\/0148607116673053.<\/p>\n
[10] Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations[J]. BMJ, 2004, 328(7454): 1490. DOI: 10.1136\/bmj.328.7454. 1490.<\/p>\n
[11] Guyatt GH, Oxman AD, Sch\u00fcnemann HJ, et al. GRADE guidelines: a new series of articles in the journal of clinical epidemiology[J]. J Clin Epidemiol, 2011, 64(4): 380-382. DOI: 10.1016\/j.jclinepi.2010.09.011.<\/p>\n
[12] Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive[J]. BMJ, 2008, 337: a744. DOI: 10.1136\/bmj.a744.<\/p>\n
[13] Bargetzi L, Brack C, Herrmann J, et al. Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial[J]. Ann Oncol, 2021, 32(8): 1025-1033. DOI: 10.1016\/j.annonc.2021.05.793.<\/p>\n
[14] Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22(3): 321-336. DOI: 10.1016\/s0261-5614(02)00214-5.<\/p>\n
[15] Schuetz P, Fehr R, Baechli V, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial[J]. Lancet, 2019, 393(10188): 2312-2321. DOI: 10.1016\/S0140-6736(18)32776-4.<\/p>\n
[16] \u4e2d\u534e\u533b\u5b66\u4f1a\u80a0\u5916\u80a0\u5185\u8425\u517b\u5b66\u5206\u4f1a. \u6210\u4eba\u8865\u5145\u6027\u80a0\u5916\u8425\u517b\u4e2d\u56fd\u4e13\u5bb6\u5171\u8bc6[J]. \u4e2d\u534e\u80c3\u80a0\u5916\u79d1\u6742\u5fd7, 2017, 20(1): 9-13. DOI: 10.3760\/cma.j.issn.1671-0274.2017.01.002.<\/p>\n
[17] Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status?[J]. JPEN J Parenter Enteral Nutr, 1987, 11(1): 8-13. DOI: 10.1177\/014860718701100108.<\/p>\n
[18] Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer[J]. Eur J Clin Nutr. 2002, 56(8): 779-785. DOI: 10.1038\/sj.ejcn.1601412. PMID: 12122555.<\/p>\n
[19] Gabrielson DK, Scaffidi D, Leung E, et al. Use of an abridged scored Patient-Generated Subjective Global Assessment (abPG-SGA) as a nutritional screening tool for cancer patients in an outpatient setting[J]. Nutr Cancer. 2013, 65(2): 234-239. DOI: 10.1080\/01635581. 2013.755554.<\/p>\n
[20] Cederholm T, Jensen GL, Correia M, et al. GLIM criteria for the diagnosis of malnutrition -aconsensus report from the global clinical nutrition community[J]. Clin Nutr, 2019, 38(1): 1-9. DOI: 10.1016\/j.clnu.2018.08.002.[21] Barazzoni R, Jensen GL, Correia M, et al. Guidance for assessment of the muscle mass phenotypic criterion for the global leadership initiative on malnutrition (GLIM) diagnosis of malnutrition[J]. Clin Nutr, 2022, 41(6): 1425-1433. DOI: 10.1016\/j.clnu.2022.02.001.<\/p>\n
[22] Cederholm T, Jensen GL, Ballesteros-Pomar MD, et al. Guidance for assessment of the inflammation etiologic criterion for the GLIM diagnosis of malnutrition: a modified Delphi approach[J]. Clin Nutr, 2023, 43(5): 1025-1032. DOI: 10.1016\/j.clnu.2023.11.026.<\/p>\n
[23] Bossi P, Delrio P, Mascheroni A, et al. The spectrum of malnutrition\/cachexia\/sarcopenia in oncology according to different cancer types and settings: a narrative review[J]. Nutrients, 2021, 13(6): 1980. DOI: 10.3390\/nu130 61980.<\/p>\n
[24] Meza-Valderrama D, Marco E, D\u00e1valos-Yerovi V, et al. Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer[J]. Nutrients, 2021, 13(3): 761. DOI: 10.3390\/nu13030761.<\/p>\n
[25] Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: clinical nutrition in cancer[J]. Clin Nutr, 2021, 40(5): 2898-2913. DOI: 10.1016\/j.clnu. 2021.02.005.<\/p>\n
[26] McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (sccm) and american society for parenteral and enteral nutrition (A.S.P.E.N.)[J]. JPEN J Parenter Enteral Nutr, 2016, 40(2): 159-211. DOI: 10.1177\/0148607115621863.<\/p>\n
[27] Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit[J]. Clin Nutr, 2019, 38(1): 48-79. DOI: 10.1016\/j.clnu.2018.08.037.<\/p>\n
[28] Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline[J]. Clin Nutr, 2022, 41(6): 1357-1424. DOI: 10.1016\/j.clnu.2022.02.015.<\/p>\n
[29] Berger MM, Shenkin A, Dizdar OS, et al. ESPEN practical short micronutrient guideline[J]. Clin Nutr, 2024, 43(3): 825-857. DOI: 10.1016\/j.clnu.2024.01.030.<\/p>\n
[30] Aubry E, Friedli N, Schuetz P, et al. Refeeding syndrome in the frail elderly population: prevention, diagnosis and management[J]. Clin Exp Gastroenterol, 2018, 11: 255-264. DOI: 10.2147\/CEG.S136429.<\/p>\n
[31] da Silva J, Seres DS, Sabino K, et al. ASPEN consensus recommendations for refeeding syndrome[J]. Nutr Clin Pract, 2020, 35(2): 178-195. DOI: 10.1002\/ncp.10474.<\/p>\n
[32] Rasmussen SO, Kristensen MB, Wessel I, et al. Incidence and risk factors of refeeding syndrome in head and neck cancer patients-an observational study[J]. Nutr Cancer, 2016, 68(8): 1320-1329. DOI: 10.1080\/01635581.2016. 1225103.<\/p>\n
[33] Hawes C, Gomes A, Byham-Gray L, et al. The effect of oral nutrition supplements and appetite stimulants on weight status among pediatric cancer patients: a systematic review[J]. Nutr Clin Pract, 2023, 38(4): 761-774. DOI: 10.1002\/ncp.10919.<\/p>\n
[34] Rinninella E, Cintoni M, Raoul P, et al. Effects of nutritional interventions on nutritional status in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials[J]. Clin Nutr ESPEN, 2020, 38: 28-42. DOI: 10.1016\/j.clnesp. 2020.05.007.<\/p>\n
[35] Caccialanza R, Laviano A, Bosetti C, et al. Clinical and economic value of oral nutrition supplements in patients with cancer: a position paper from the Survivorship Care and Nutritional Support Working Group of Alliance Against Cancer[J]. Support Care Cancer, 2022, 30(11): 9667-9679. DOI: 10.1007\/s00520-022-07269-y.<\/p>\n
[36] Kristensen MB, Isenring E, Brown B. Nutrition and swallowing therapy strategies for patients with head and neck cancer[J]. Nutrition, 2020, 69: 110548. DOI: 10.1016\/j.nut.2019.06.028.<\/p>\n
[37] M\u00e4kitie AA, Alabi RO, Orell H, et al. Managing cachexia in head and neck cancer: a systematic scoping review[J]. Adv Ther, 2022, 39(4): 1502-1523. DOI: 10.1007\/s12325-022-02074-9.<\/p>\n
[38] Talwar B, Donnelly R, Skelly R, et al. Nutritional management in head and neck cancer: united kingdom national multidisciplinary guidelines[J]. J Laryngol Otol, 2016, 130(S2): S32-S40. DOI: 10.1017\/S002221511 6000402.<\/p>\n
[39] de van der Schueren M, Laviano A, Blanchard H, et al. Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials[J]. Ann Oncol, 2018, 29(5): 1141-1153. DOI: 10.1093\/annonc\/mdy114.<\/p>\n
[40] Kim SH, Lee SM, Jeung HC, et al. The effect of nutrition intervention with oral nutritional supplements on pancreatic and bile duct cancer patients undergoing chemotherapy[J]. Nutrients, 2019, 11(5): 1145. DOI: 10.3390\/nu11051145.<\/p>\n
[41] Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery[J]. Clin Nutr, 2017, 36(3): 623-650. DOI: 10.1016\/j.clnu.2017.02.013.<\/p>\n
[42] Tan S, Meng Q, Jiang Y, et al. Impact of oral nutritional supplements in post-discharge patients at nutritional risk following colorectal cancer surgery: a randomised clinical trial[J]. Clin Nutr, 2021, 40(1): 47-53. DOI: 10.1016\/j.clnu.2020.05.038.<\/p>\n
[43] Meng Q, Tan S, Jiang Y, et al. Post-discharge oral nutritional supplements with dietary advice in patients at nutritional risk after surgery for gastric cancer: a randomized clinical trial[J]. Clin Nutr, 2021, 40(1): 40-46. DOI: 10.1016\/j.clnu.2020.04.043.<\/p>\n
[44] Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38(2): 485-521. DOI: 10.1016\/j.clnu.2018.12.022.<\/p>\n
[45] Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics[J]. Clin Nutr, 2019, 38(1): 10-47. DOI: 10.1016\/j.clnu.2018. 05.024.<\/p>\n
[46] Arvanitakis M, Ockenga J, Bezmarevic M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis[J]. Clin Nutr, 2020, 39(3): 612-631. DOI: 10.1016\/j.clnu.2020.01.004.<\/p>\n
[47] Bischoff SC, Escher J, H\u00e9buterne X, et al. ESPEN practical guideline: clinical nutrition in inflammatory bowel disease[J]. Clin Nutr, 2020, 39(3): 632-653. DOI: 10.1016\/j.clnu.2019.11.002.<\/p>\n
[48] Bischoff SC, Austin P, Boeykens K, et al. ESPEN guideline on home enteral nutrition[J]. Clin Nutr, 2020, 39(1): 5-22. DOI: 10.1016\/j.clnu.2019.04.022.<\/p>\n
[49] Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. definition and classification of intestinal failure in adults[J]. Clin Nutr, 2015, 34(2): 171-180. DOI: 10.1016\/j.clnu.2014.08.017.<\/p>\n
[50] Minor G, Sentongo T, Heine RG, et al. Tolerability and safety of a semi-elemental enteral formula with partially hydrolyzed guar gum (PHGG) in tube-fed children aged 1-4 years: an open-label, single-arm study[J]. Clin Nutr ESPEN, 2023, 55: 392-399. DOI: 10.1016\/j.clnesp. 2023.04.004.<\/p>\n
[51] Carteron L, Samain E, Winiszewski H, et al. Semi-elemental versus polymeric formula for enteral nutrition in brain-injured critically ill patients: a randomized trial[J]. Crit Care, 2021, 25(1): 31. DOI: 10.1186\/s13054-020-03456-7.<\/p>\n
[52] Rooze S, Namane SA, Beretta X, et al. Is a semi-elemental diet better than a polymeric diet after congenital heart surgery?[J]. Eur J Pediatr, 2020, 179(3): 423-430. DOI: 10.1007\/s00431-019-03505-6.<\/p>\n
[53] Klek S, Forbes A, Gabe S, et al. Management of acute intestinal failure: a position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group[J]. Clin Nutr, 2016, 35(6): 1209-1218. DOI: 10.1016\/j.clnu.2016.04.009.<\/p>\n
[54] Pironi L, Corcos O, Forbes A, et al. Intestinal failure in adults: recommendations from the ESPEN expert groups[J]. Clin Nutr, 2018, 37(6 Pt A): 1798-1809. DOI: 10.1016\/j.clnu.2018.07.036.<\/p>\n
[55] Hiestand A, Flory J, Chitkara R. Hospitalization as an opportunity to optimize glycemic control in oncology patients[J]. Curr Diab Rep, 2019, 19(12): 149. DOI: 10.1007\/s11892-019-1283-6.<\/p>\n
[56] Mulla K, Farag S, Moore B, et al. Hyperglycaemia following immune checkpoint inhibitor therapy- incidence, aetiology and assessment[J]. Diabet Med, 2023, 40(4): e15053. DOI: 10.1111\/dme.15053.<\/p>\n
[57] Xu KY, Shameem R, Wu S. Risk of hyperglycemia attributable to everolimus in cancer patients: a meta-analysis[J]. Acta Oncol, 2016, 55(9-10): 1196-1203. DOI: 10.3109\/0284186X.2016.1168939.<\/p>\n
[58] Ojo O, Weldon SM, Thompson T, et al. The effect of diabetes-specific enteral nutrition formula on cardiometabolic parameters in patients with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials[J]. Nutrients, 2019, 11(8): 1905. DOI: 10.3390\/nu11081905.<\/p>\n
[59] Sanz-Par\u00eds A, Mat\u00eda-Mart\u00edn P, Mart\u00edn-Palmero \u00c1, et al. Diabetes-specific formulas high in monounsaturated fatty acids and metabolic outcomes in patients with diabetes or hyperglycaemia: a systematic review and meta-analysis[J]. Clin Nutr, 2020, 39(11): 3273-3282. DOI: 10.1016\/j.clnu.2020.02.036.<\/p>\n
[60] \u4e2d\u56fd\u533b\u7597\u4fdd\u5065\u56fd\u9645\u4ea4\u6d41\u4fc3\u8fdb\u4f1a\u8425\u517b\u4e0e\u4ee3\u8c22\u7ba1\u7406\u5206\u4f1a, \u4e2d\u56fd\u8425\u517b\u5b66\u4f1a\u4e34\u5e8a\u8425\u517b\u5206\u4f1a, \u4e2d\u534e\u533b\u5b66\u4f1a\u7cd6\u5c3f\u75c5\u5b66\u5206\u4f1a, \u7b49. \u4e2d\u56fd\u7cd6\u5c3f\u75c5\u533b\u5b66\u8425\u517b\u6cbb\u7597\u6307\u5357(2022\u7248)[J]. \u4e2d\u534e\u7cd6\u5c3f\u75c5\u6742\u5fd7, 2022, 14(9): 881-933. DOI: 10.3760\/cma.j.cn115791-20220704-00324.[61] Guo K, Wang Z, Luo R, et al. Association between chronic kidney disease and cancer including the mortality of cancer patients: national health and nutrition examination survey 1999-2014[J]. Am J Transl Res, 2022, 14(4): 2356-2366.<\/p>\n
[62] Shirali AC, Sprangers B. Cancer drug dosing in chronic kidney disease and dialysis[J]. Adv Chronic Kidney Dis, 2022, 29(2): 208-216.e1. DOI: 10.1053\/j.ackd.2021. 12.002.<\/p>\n
[63] Lee M, Wang Q, Wanchoo R, et al. Chronic kidney disease in cancer survivors[J]. Adv Chronic Kidney Dis, 2021, 28(5): 469-476.e1. DOI: 10.1053\/j.ackd.2021.10.007.<\/p>\n
[64] Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update[J]. Am J Kidney Dis. 2020 Sep;76(3 Suppl 1): S1-S107. DOI: 10.1053\/j.ajkd.2020.05.006.<\/p>\n
[65] Fiaccadori E, Sabatino A, Barazzoni R, et al. ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease[J]. Clin Nutr, 2021, 40(4): 1644-1668. DOI: 10.1016\/j.clnu.2021.01.028.<\/p>\n
[66] \u4e2d\u56fd\u533b\u5e08\u534f\u4f1a\u80be\u810f\u5185\u79d1\u533b\u5e08\u5206\u4f1a, \u4e2d\u56fd\u4e2d\u897f\u533b\u7ed3\u5408\u5b66\u4f1a\u80be\u810f\u75be\u75c5\u4e13\u4e1a\u59d4\u5458\u4f1a\u8425\u517b\u6cbb\u7597\u6307\u5357\u4e13\u5bb6\u534f\u4f5c\u7ec4. \u4e2d\u56fd\u6162\u6027\u80be\u810f\u75c5\u8425\u517b\u6cbb\u7597\u4e34\u5e8a\u5b9e\u8df5\u6307\u5357(2021\u7248)[J]. \u4e2d\u534e\u533b\u5b66\u6742\u5fd7, 2021, 101(8): 539-559. DOI: 10.3760\/cma.j.cn112137-20201211-03338.<\/p>\n
[67] Brown RO, Compher C, American Society for Parenteral and Enteral Nutrition Board of Directors, et al. A.s.p.e.n. clinical guidelines: nutrition support in adult acute and chronic renal failure[J]. JPEN J Parenter Enteral Nutr, 2010, 34(4): 366-377. DOI: 10.1177\/01486071103 74577.<\/p>\n
[68] Preiser JC, Arabi YM, Berger MM, et al. A guide to enteral nutrition in intensive care units: 10 expert tips for the daily practice[J]. Crit Care, 2021, 25(1): 424. DOI: 10.1186\/s13054-021-03847-4.<\/p>\n
[69] Bischoff SC, Bernal W, Dasarathy S, et al. ESPEN practical guideline: clinical nutrition in liver disease[J]. Clin Nutr, 2020, 39(12): 3533-3562. DOI: 10.1016\/j.clnu.2020. 09.001.<\/p>\n
[70] Probst P, Ohmann S, Klaiber U, et al. Meta-analysis of immunonutrition in major abdominal surgery[J]. Br J Surg, 2017, 104(12): 1594-1608. DOI: 10.1002\/bjs. 10659.<\/p>\n
[71] Ricci C, Serbassi F, Alberici L, et al. Immunonutrition in patients who underwent major abdominal surgery: a comprehensive systematic review and component network metanalysis using GRADE and cineMA approaches[J]. Surgery, 2023, 174(6): 1401-1409. DOI: 10.1016\/j.surg.2023.08.005.<\/p>\n
[72] Yu K, Zheng X, Wang G, et al. Immunonutrition vs standard nutrition for cancer patients: a systematic review and meta-analysis (part 1)[J]. JPEN J Parenter Enteral Nutr, 2020, 44(5): 742-767. DOI: 10.1002\/jpen.1736.<\/p>\n
[73] Compher C, Bingham AL, McCall M, et al. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: the american society for parenteral and enteral nutrition[J]. JPEN J Parenter Enteral Nutr, 2022, 46(1): 12-41. DOI: 10.1002\/jpen.2267.<\/p>\n
[74] Faber J, Berkhout M, Fiedler U, et al. Rapid EPA and DHA incorporation and reduced pge2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy, a randomized trial[J]. Clin Nutr, 2013, 32(3): 338-345. DOI: 10.1016\/j.clnu.2012.09.009.<\/p>\n
[75] Talvas J, Garrait G, Goncalves-Mendes N, et al. Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: a double-blind randomized clinical trial[J]. Clin Nutr, 2015, 34(5): 810-817. DOI: 10.1016\/j.clnu.2014.12.002.<\/p>\n
[76] Kavalukas S, McClave SA. Immunonutrition vs standard nutrition for patients with cancer[J]. Nutr Clin Pract, 2023, 38(4): 924-931. DOI: 10.1002\/ncp.10963.<\/p>\n
[77] Fietkau R, Lewitzki V, Kuhnt T, et al. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial[J]. Cancer, 2013, 119(18): 3343-3353. DOI: 10.1002\/cncr. 28197.<\/p>\n
[78] Hole\u010dek M. Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions[J]. J Cachexia Sarcopenia Muscle, 2017, 8(4): 529-541. DOI: 10.1002\/jcsm.12208.<\/p>\n
[79] Prado CM, Orsso CE, Pereira SL, et al. Effects of \u03b2-hydroxy \u03b2-methylbutyrate (hmb) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review[J]. J Cachexia Sarcopenia Muscle, 2022, 13(3): 1623-1641. DOI: 10.1002\/jcsm.12952.<\/p>\n
[80] Pereira SL, Shoemaker ME, Gawel S, et al. Biomarker changes in response to a 12-week supplementation of an oral nutritional supplement enriched with protein, vitamin D and HMB in malnourished community dwelling older adults with sarcopenia[J]. Nutrients, 2022, 14(6): 1196. DOI: 10.3390\/nu14061196.<\/p>\n
[81] Deutz NE, Matheson EM, Matarese LE, et al. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial[J]. Clin Nutr, 2016, 35(1): 18-26. DOI: 10.1016\/j.clnu.2015.12.010.<\/p>\n
[82] Rosenthal MD, Carrott PW, Patel J, et al. Parenteral or enteral arginine supplementation safety and efficacy[J]. J Nutr, 2016, 146(12): 2594S-2600S. DOI: 10.3945\/jn.115. 228544.<\/p>\n
[83] Nazarian B, Fazeli Moghadam E, Asbaghi O, et al. Effect of l-arginine supplementation on c-reactive protein and other inflammatory biomarkers: a systematic review and meta-analysis of randomized controlled trials[J]. Complement Ther Med, 2019, 47: 102226. DOI: 10.1016\/j.ctim.2019.102226.<\/p>\n
[84] Okamoto Y, Sakaguchi T, Ikematsu Y, et al. Early enteral nutrition with arginine compensates for negative nitrogen balance in patients undergoing curative total gastrectomy[J]. J Med Invest, 2023, 70(3.4): 325-333. DOI: 10.2152\/jmi.70.325.<\/p>\n
[85] Pathanki AM, Attard JA, Bradley E, et al. Pancreatic exocrine insufficiency after pancreaticoduodenectomy: current evidence and management[J]. World J Gastrointest Pathophysiol, 2020, 11(2): 20-31. DOI: 10.4291\/wjgp.v11.i2.20.<\/p>\n
[86] Singh S, Midha S, Singh N, et al. Dietary counseling versus dietary supplements for malnutrition in chronic pancreatitis: a randomized controlled trial[J]. Clin Gastroenterol Hepatol, 2008, 6(3): 353-359. DOI: 10.1016\/j.cgh.2007.12.040.<\/p>\n
[87] Gluud LL, Dam G, Les I, et al. Branched-chain amino acids for people with hepatic encephalopathy[J]. Cochrane Database Syst Rev, 2017, 5(5): CD001939. DOI: 10.1002\/14651858.CD001939.pub4.<\/p>\n
[88] Les I, Doval E, Garc\u00eda-Mart\u00ednez R, et al. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study[J]. Am J Gastroenterol, 2011, 106(6): 1081-1088. DOI: 10.1038\/ajg.2011.9.<\/p>\n
[89] Arends J, Strasser F, Gonella S, et al. Cancer cachexia in adult patients: ESMO clinical practice guidelines[J]. ESMO Open, 2021, 6(3): 100092. DOI: 10.1016\/j.esmoop. 2021.100092.<\/p>\n","protected":false},"excerpt":{"rendered":"
\u5eb7\u519b\u4ec1 \u4e8e\u5eb7 \u4e2d\u56fd\u8425\u517b\u5b66\u4f1a\u80bf\u7624\u8425\u517b\u7ba1 … \u7ee7\u7eed\u9605\u8bfb